
Maris R. Kessel
Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )
| Most Active Art Unit | 1759 |
| Art Unit(s) | 1795, 1759, 1758, 1699 |
| Total Applications | 485 |
| Issued Applications | 239 |
| Pending Applications | 11 |
| Abandoned Applications | 232 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14762039
[patent_doc_number] => 10392404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Compounds and compositions as kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/510613
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38953
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510613 | Compounds and compositions as kinase inhibitors | Sep 10, 2015 | Issued |
Array
(
[id] => 11949459
[patent_doc_number] => 20170253607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'LONG-ACTING HIV PROTEASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/509049
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85532
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509049
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509049 | LONG-ACTING HIV PROTEASE INHIBITOR | Sep 9, 2015 | Abandoned |
Array
(
[id] => 12057172
[patent_doc_number] => 20170333516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'PREVENTIVE OR THERAPEUTIC AGENT FOR AGE-RELATED MACULAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 15/525660
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2747
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525660 | Preventive or therapeutic agent for age-related macular degeneration | Sep 8, 2015 | Issued |
Array
(
[id] => 11936411
[patent_doc_number] => 20170240561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'PROCESS FOR THE PREPARATION OF MACROCYCLIC KETONE ANALOGS OF HALICHONDRIN B OR PHARMACEUTICALLY ACCEPTABLE SALTS AND INTERMEDIATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/510077
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8644
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510077
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510077 | Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof | Sep 8, 2015 | Issued |
Array
(
[id] => 11943192
[patent_doc_number] => 20170247343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'THIOETHER TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE'
[patent_app_type] => utility
[patent_app_number] => 15/510150
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32150
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510150 | THIOETHER TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE | Sep 8, 2015 | Abandoned |
Array
(
[id] => 12144801
[patent_doc_number] => 09879042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Human iNKT cell activation using glycolipids'
[patent_app_type] => utility
[patent_app_number] => 14/847835
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 42229
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14847835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/847835 | Human iNKT cell activation using glycolipids | Sep 7, 2015 | Issued |
Array
(
[id] => 11979245
[patent_doc_number] => 20170283399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Crystalline Forms of 6-((6,7-Dimethoxyquinazolin-4-yl)oxy)-N,2-Dimethylbenzofuran-3-Carboxamide'
[patent_app_type] => utility
[patent_app_number] => 15/510631
[patent_app_country] => US
[patent_app_date] => 2015-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19341
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510631 | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide | Sep 6, 2015 | Issued |
Array
(
[id] => 13814383
[patent_doc_number] => 10183952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Thienopyrroles as histone demethylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/508816
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31830
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508816 | Thienopyrroles as histone demethylase inhibitors | Sep 3, 2015 | Issued |
Array
(
[id] => 10729528
[patent_doc_number] => 20160075678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'FACILE AND SELECTIVE PERFLUORO-AND POLYFLUOROARYLATION OF MELDRUMS ACID'
[patent_app_type] => utility
[patent_app_number] => 14/840951
[patent_app_country] => US
[patent_app_date] => 2015-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3703
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14840951
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/840951 | Facile and selective perfluoro-and polyfluoroarylation of meldrums acid | Aug 30, 2015 | Issued |
Array
(
[id] => 10791478
[patent_doc_number] => 20160137634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'Chemical Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/840209
[patent_app_country] => US
[patent_app_date] => 2015-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 48739
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14840209
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/840209 | Chemical compounds | Aug 30, 2015 | Issued |
Array
(
[id] => 13093223
[patent_doc_number] => 10065942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{[1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol
[patent_app_type] => utility
[patent_app_number] => 15/505740
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5676
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505740
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/505740 | Crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{[1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol | Aug 27, 2015 | Issued |
Array
(
[id] => 10654634
[patent_doc_number] => 20160000778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 14/829234
[patent_app_country] => US
[patent_app_date] => 2015-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10524
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14829234
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/829234 | COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION | Aug 17, 2015 | Abandoned |
Array
(
[id] => 11750270
[patent_doc_number] => 09708273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators'
[patent_app_type] => utility
[patent_app_number] => 14/828216
[patent_app_country] => US
[patent_app_date] => 2015-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21064
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14828216
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/828216 | Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators | Aug 16, 2015 | Issued |
Array
(
[id] => 11869721
[patent_doc_number] => 20170237005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 15/504463
[patent_app_country] => US
[patent_app_date] => 2015-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 35984
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504463
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504463 | Process for preparing a crystalline organic semiconductor material | Aug 16, 2015 | Issued |
Array
(
[id] => 13251079
[patent_doc_number] => 10138218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Process for preparing furfural from biomass
[patent_app_type] => utility
[patent_app_number] => 15/502897
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13297
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502897
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502897 | Process for preparing furfural from biomass | Aug 12, 2015 | Issued |
Array
(
[id] => 11441175
[patent_doc_number] => 20170042196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'USE OF UMAMI COMPOUNDS TO ENHANCE SALTINESS'
[patent_app_type] => utility
[patent_app_number] => 14/823920
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13246
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14823920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/823920 | USE OF UMAMI COMPOUNDS TO ENHANCE SALTINESS | Aug 10, 2015 | Abandoned |
Array
(
[id] => 10459436
[patent_doc_number] => 20150344452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'PROCASPASE ACTIVATING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/822830
[patent_app_country] => US
[patent_app_date] => 2015-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26504
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14822830
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/822830 | Procaspase activating compounds | Aug 9, 2015 | Issued |
Array
(
[id] => 11836200
[patent_doc_number] => 20170217918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'ANTIDIABETIC BICYCLIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/328735
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86266
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328735 | Antidiabetic bicyclic compounds | Aug 5, 2015 | Issued |
Array
(
[id] => 13916503
[patent_doc_number] => 10202358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Energy-efficient and environmentally friendly process for the production of target chemical compounds from cellulosic material
[patent_app_type] => utility
[patent_app_number] => 15/501482
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 5262
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501482
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501482 | Energy-efficient and environmentally friendly process for the production of target chemical compounds from cellulosic material | Jul 29, 2015 | Issued |
Array
(
[id] => 14360033
[patent_doc_number] => 10301303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof
[patent_app_type] => utility
[patent_app_number] => 15/303468
[patent_app_country] => US
[patent_app_date] => 2015-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 21219
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303468
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/303468 | Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof | Jul 27, 2015 | Issued |